SCHEMBL6538814

SCHEMBL6538814

C[SiH](C)OCCN=C=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL678193 0.72
SCHEMBL330829 0.71 NAAA (0.55)
SCHEMBL29410061 0.69 NAAA (0.59)
SCHEMBL21406523 0.68
SCHEMBL8762328 0.67
SCHEMBL9906573 0.67
SCHEMBL31395027 0.66
SCHEMBL483904 0.66
SCHEMBL13207710 0.65
SCHEMBL15228548 0.65 NAAA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114369097-B Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2023-07-14 CN disclosed
CN-114369097-A Heteroaromatic AhR inhibitors 山东轩竹医药科技有限公司 2022-04-19 CN disclosed
CN-107922423-B Nitrogen-containing tricyclic derivatives having HIV replication inhibiting effect 盐野义制药株式会社 2020-10-27 CN disclosed
CN-111138458-A Nitrogen-containing tricyclic derivatives having HIV replication inhibiting effect 盐野义制药株式会社 2020-05-12 CN disclosed
EP-1381593-A2 (2-HYDROXY)ETHYL-THIOUREAS USEFUL AS MODULATORS OF ALPHA2B ADRENERGIC RECEPTORS Allergan, Inc. (US) 2004-01-21 EP disclosed
WO-2002068384-A2 (2-HYDROXY)ETHYL-THIOUREAS USEFUL AS MODULATORS OF ALPHA2B ADRENERGIC RECEPTORS ALLERGAN, INC. (US) 2002-09-06 WO disclosed